The EEF2K Knockout K-562 Polyclonal Cells provide a CRISPR/Cas9-edited polyclonal knockout population designed for targeted disruption of the eukaryotic elongation factor 2 kinase (EEF2K) gene in a human leukemia model. This genetically heterogeneous cell population serves as a robust loss-of-function system to investigate EEF2K-dependent regulatory mechanisms without clonal selection bias. The polyclonal format ensures retention of diverse genetic backgrounds, enabling studies that reflect population-level responses to gene ablation. Researchers can employ this model to dissect EEF2K-mediated translation control and stress adaptation, with applications spanning cancer biology, signal transduction, and autophagy research.
The host cell line, K-562, is a suspension lymphoblast line derived from a chronic myelogenous leukemia (CML) patient in blast crisis. It harbors the BCR-ABL1 fusion oncogene and exhibits Philadelphia chromosome positivity, making it a well-characterized model for hematopoietic malignancies, leukemia cell proliferation, and hematopoiesis. K-562 cells grow in suspension and display undifferentiated blast morphology, offering a versatile platform for studying kinase signaling, drug resistance, and translational regulation in a leukemic context. Their genetic background is widely used to examine oncogene-driven signaling networks and to screen therapeutic agents targeting translation and stress pathways.
EEF2K functions as a negative regulator of translation elongation by phosphorylating its primary downstream target, eukaryotic elongation factor 2 (eEF2), at Thr56, which reduces eEF2 affinity for ribosomes and slows peptide chain elongation. This kinase integrates signals from multiple upstream pathways, including AMPK, mTORC1, Ca2+/calmodulin, PKA, and cAMP. Activation of EEF2K is triggered by cellular energy stress via AMPK, calmodulin-dependent calcium signaling, and cAMP/PKA cascades, while mTORC1 negatively regulates its activity. EEF2K interacts directly with calmodulin and associates with 14-3-3 proteins, which modulate its subcellular localization and stability. The EEF2K-eEF2 axis serves as a converging node that connects mTOR, AMPK, S6K, and calmodulin signaling to translational output, balancing protein synthesis with metabolic demands and stress responses.
In K-562 leukemia cells, EEF2K disruption offers a unique opportunity to interrogate the interplay between oncogenic BCR-ABL signaling and translation elongation control. Since K-562 cells are addicted to constitutive kinase activity and elevated translation rates, removal of EEF2K-mediated translational braking may sensitize cells to nutrient deprivation or chemotherapeutics. This model is particularly valuable for studying adaptive responses to energy stress, autophagy induction, and the development of drug resistance in CML. The polyclonal knockout population allows researchers to assess heterogeneous cellular behaviors, including clonal variability in stress tolerance, proliferation, and apoptosis, closely mimicking intratumoral diversity.
Researchers can utilize these polyclonal knockout cells in a variety of experimental workflows to dissect EEF2K biology. Typical applications include evaluating leukemia cell proliferation and viability under normal and stress conditions, investigating mechanisms of drug resistance to tyrosine kinase inhibitors, and modulating autophagy flux. Compatible assays range from western blotting for EEF2K and phosphorylated eEF2 (p-eEF2) to RT-qPCR, flow cytometry for cell cycle and apoptosis, viability assays, and autophagy flux measurements. Downstream signaling analysis can encompass phospho-AMPK, mTOR, and S6K activation status. This product serves as a flexible tool for translational control and stress response research in a leukemic background. For further details, please contact Ascent Research.
